SHL Medical announced today the release of its Sustainability Report for 2022. The report provides a comprehensive overview of the company’s efforts to promote sustainability and outlines its commitment to a sustainable future.
SHL Medical achieves ISO 14001 Environmental Management Systems certification and ISO 45001 Occupational Health and Safety Management Systems certification.
SHL Medical is pleased to announce our participation in CPHI Japan 2023 for the first time.
SHL Medical is pleased to announce the appointment of Satbir Bains as Chief Human Resources Officer (CHRO) of SHL and a member of the Executive Management Team as of February 2023.
SHL Medical is opening 2023 with our participation in Pharmapack Europe.
SHL Medical is excited to announce our first-time participation in the NSTC Science Train Program, 2022.
SHL Medical wins 2022 Excellence Quality Practice Award.
SHL Medical’s FATM and Maggie 5.0 autoinjector are finalists for CPHI Pharma Awards 2022.
SHL will exhibit at the 2022 Prefilled Syringe Seminar (PFSS) Tokyo organized by Parenteral Drug Association (PDA) Japan.